China’s Biopharma Industry

Market prospects and investment paths Biopharma, short for biopharmaceuticals, are medical products produced using biotechnology (or biotech). Typical biopharma products include pharmaceuticals generated from living organisms, vaccines and gene therapy, among others. China’s biopharma industry has much attention home and abroad, especially after Chinese companies…

Bureaucracy Hurdles

Invisible market access barriers when doing business in China

On the Perimeter of the Economic Circle

Market access barriers in the burgeoning market of Southwest China

All Eyes on ESG

Why businesses in China need to prepare for changes in regulation, buyer behaviour and the digital landscape

China in the World Trade Organization: 20 years on

Interview with Adam Dunnett, secretary general, European Union Chamber of Commerce in China[1]

Cautious Optimism

Asian private equity industry outlook favourable thanks to ongoing digitalisation trend

China’s Service Sector at a Glance

Investment opportunities for foreign-owned companies

Invigilating Foreign Investors

China’s new security review measures for speculation in ‘sensitive’ areas